Capital Flow Monitor · Sponsors · CIK 1723443
InSitu Biologics, Inc.
3510 HOPKINS PLACE N., OAKDALE, MN, 55128 · 651-337-4799
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$8.0M
Sold
$4.0M
% sold
49.4%
Investors
29
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | D | 506(b) | $2.5M | $1.3M | 50.0% | 1 | EDGAR ↗ |
| 2025-12-18 | D ·current | 506(b) | $8.0M | $4.0M | 49.4% | 29 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Daniel Halpern — Executive Officer / Director, Oakdale, MN
- Bill Taylor — Executive Officer, Oakdale, MN
- Sandi Klemann — Executive Officer, Oakdale, MN
- Robert Wilson — Director, Oakdale, MN
-
Greg Van Guilder — Director, Oakdale, MN
1 other raise
- Preceptis Medical, Inc. $2.6M of $6.9M · 37.1%
- Ivan Shaw — Director, Oakdale, MN
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.